Biological sex profoundly shapes how the immune system responds to infection, vaccination, and autoimmune triggers. Estrogens, progesterone, and androgens directly regulate the development, activation, and functional behaviour of both adaptive and innate immune cells, producing measurable differences in infection susceptibility, vaccine efficacy, and disease risk between males and females. Understanding these sex-based immunological variations is essential for precision medicine and explaining why certain populations respond differently to the same therapeutic interventions.
Key takeaways
- Females exhibit higher counts of activated CD4⁺ and CD8⁺ T cells and produce broader antibody responses than males, contributing to stronger adaptive immunity
- Regulatory T cells (Tregs) are more abundant and functionally robust in males, providing stronger immune tolerance and potentially explaining lower autoimmunity rates
- Innate immune cells—neutrophils, monocytes, macrophages, and dendritic cells—show hormone-dependent differences in lifespan, killing capacity, and inflammatory output
- Sex-based immune differences have direct clinical implications for infection outcomes, vaccine response, and risk of inflammatory and autoimmune diseases
Sex-Based Differences in Immune Cell Populations and Function
Adaptive and innate immune compartments show hormone-dependent variation between males and females
Source: Sex hormone immunomodulation literature synthesis | Georgian Medical Journal News
The Adaptive Immune System: How Sex Hormones Amplify or Dampen T and B Cell Responses
The adaptive immune system—the body’s antigen-specific defense mechanism—shows marked sex-dependent variation in both cellular composition and functional capacity. Females typically demonstrate higher absolute numbers of activated CD4⁺ helper T cells and CD8⁺ cytotoxic T cells, translating to more robust cell-mediated immunity against pathogens. Additionally, female B cells produce broader, more diverse antibody responses to the same antigen challenge, a phenomenon directly attributable to estrogen’s role in promoting B-cell activation and plasma cell differentiation. Research into vaccine immunogenicity has consistently documented these differences, with females often mounting stronger serological responses to routine vaccinations including influenza and COVID-19 vaccines.
In contrast, males show a distinct immunoregulatory bias: regulatory T cells (Tregs)—specialized cells that suppress excessive immune activation—are more abundant and functionally robust in the male immune system. This elevated Treg activity provides stronger immune tolerance, potentially protecting males from excessive inflammatory responses but also making them more susceptible to certain infections where strong effector T-cell responses are protective. This sex-dependent balance between effector immunity (females) and immune regulation (males) has profound implications for understanding sex differences in infection outcomes, vaccine responses, and autoimmune disease prevalence. Emerging immunological research continues to dissect the molecular mechanisms by which estrogens and androgens influence these adaptive compartments, revealing direct transcriptional effects on T-cell and B-cell gene expression.
Females maintain higher CD4⁺ and CD8⁺ T-cell counts and activation states, along with broader antibody responses, whereas males exhibit more abundant and functionally robust regulatory T cells, reflecting sex hormone-driven immunological specialization
— Sex hormone immunoregulation literature
Innate Immunity and Sex Hormones: Neutrophils, Monocytes, and Antigen-Presenting Cells
The innate immune system’s first-responder cells—neutrophils, monocytes, macrophages, and dendritic cells—are not immune to sex hormone signalling. These myeloid populations demonstrate hormone-dependent differences in several critical functions: cellular longevity, phagocytic (killing) capacity, cytokine production bias, and antigen-presenting activity. Females typically show enhanced effector and antigen-presenting responses from dendritic cells and macrophages, priming stronger downstream T-cell activation. In contrast, males often exhibit higher baseline pro-inflammatory cytokine output (tumour necrosis factor-α, interleukin-6) from select monocyte and macrophage subsets, suggesting a pro-inflammatory innate immune phenotype. Natural killer (NK) cells, which provide rapid, non-specific cytotoxic killing of infected cells, also display sex-dependent functional variation, with females often showing enhanced NK cell activation in response to viral challenge.
These sex-based innate immune differences have immediate clinical relevance: they help explain why males and females show different susceptibility to certain infections, experience different severity outcomes from sepsis and respiratory infections, and respond differently to inflammatory triggers. The molecular mechanisms involve both direct hormone signalling through oestrogen receptors and androgen receptors on myeloid cells, as well as indirect effects via hormonal modulation of lymphoid cell populations that in turn influence myeloid function. Clinical updates on infection management increasingly recognise sex as a critical variable in predicting immune response phenotype and treatment efficacy.
Clinical Implications: Why Sex Matters for Infection, Vaccination, and Autoimmunity Risk
The sex-based immunological differences documented above translate directly into observable clinical patterns. Females mount stronger antibody responses to most routine vaccines—a phenomenon well-established for influenza, measles, mumps, rubella, and hepatitis B vaccines—yet simultaneously show higher prevalence of autoimmune diseases including systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis. This apparent paradox reflects the immunological trade-off inherent in female-biased adaptive immunity: enhanced effector responses protect against pathogens but increase risk of autoimmune activation when self-tolerance breaks down. Conversely, males’ immunoregulatory advantages (elevated Tregs, higher pro-inflammatory bias) may provide protection against certain autoimmune conditions but potentially increase vulnerability to specific infections where robust adaptive responses are necessary.
For clinical practice, these sex-based differences underscore why personalised patient care must account for biological sex not as a demographic variable but as a fundamental driver of immune phenotype. Vaccine dosing, timing of revaccination, and interpretation of immunogenicity data differ between sexes; infection severity predictions and inflammatory disease risk stratification must incorporate sex-based immunological profiles; and treatment response—whether to immunotherapy, infection management, or autoimmune disease control—reflects sex-dependent immune starting conditions. This is not a matter of gender identity or social factors, but of measurable biological differences in how oestrogen, progesterone, and androgens programme immune cell function from development through adulthood.
What this means
Frequently asked questions
Why do females get higher antibody levels from vaccines than males?
Female sex hormones, particularly estrogen, directly enhance B-cell activation and antibody production. Estrogen acts on oestrogen receptors present on B cells, promoting their proliferation and differentiation into antibody-secreting plasma cells. This creates a measurable sex difference in vaccine immunogenicity across most routine vaccines, explaining why females often achieve higher anti-pathogen antibody titres with standard doses.
If females have stronger immune responses, why do they have more autoimmune disease?
This paradox reflects the inherent trade-off between strong pathogen defence and immune self-tolerance. The same hormonal and cellular mechanisms that amplify antibody production and T-cell activation in females also increase the risk of autoreactive B and T cells escaping regulatory mechanisms and attacking self-tissue. Males’ higher regulatory T-cell abundance provides stronger immune tolerance, protecting against autoimmunity but potentially reducing protective immunity to some pathogens.
Do sex hormone differences in immunity affect treatment choices for infections?
Yes, increasingly so. Sex-based immune phenotypes influence both susceptibility to infection and response to treatment. Males may experience more severe pro-inflammatory responses to certain pathogens, warranting earlier anti-inflammatory intervention; females may achieve higher antibiotic or antiviral concentrations needed for cure due to sex differences in drug metabolism driven in part by immune cell function. Personalised infection management increasingly incorporates biological sex as a predictive variable.
The emerging field of sex-specific immunology represents a paradigm shift in how medicine understands immune function and disease risk. Rather than treating biological sex as a demographic confound to be statistically adjusted, precision medicine now recognises it as a fundamental biological variable that shapes immune cell development, activation, and functional output across the lifespan. As health policy frameworks increasingly mandate sex-inclusive research and medical journals raise the bar for reporting sex-disaggregated immunological data, clinicians and public health officials will gain sharper tools for predicting infection outcomes, optimising vaccine strategies, and managing inflammatory disease across populations. Understanding how hormones programme immunity is not peripheral to clinical practice—it is foundational to effective, evidence-based care.
Source: Sex Hormones as Regulators of Immune Cell Function — Original synthesis from immunology literature
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
